SCHEMBL8335182

SCHEMBL8335182

Cc1cccc(CN(C(=O)CN(C2=C/C/C=C\C=N/C/C=C\2)S(=O)(=O)c2ccc(C(C)(C)C)cc2)C2CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 3/20 0.38
HCRTR2 O43614 2/20 0.37
TAS2R14 Q9NYV8 1/20 0.33
TRPM8 Q7Z2W7 3/20 0.32
KEAP1 Q14145 1/20 0.32
NFE2L2 Q16236 1/20 0.32
LMNA P02545 3/20 0.32
MAPT P10636 3/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CA12 O43570 2/20 0.31
CA1 P00915 2/20 0.31
CA2 P00918 2/20 0.31
CA4 P22748 2/20 0.31
CA9 Q16790 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
MC4R P32245 1/20 0.31
MC5R P33032 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12956108 0.91 TAS2R14 (0.36) TAS2R14KEAP1NFE2L2LMNAMAPT
SCHEMBL1037038 0.81 HCRTR2 (0.57) TACR1HCRTR2KEAP1NFE2L2MAPT
SCHEMBL1040591 0.77 HCRTR2 (0.46) TACR1HCRTR2TAS2R14KEAP1NFE2L2
SCHEMBL1039701 0.75 KEAP1 (0.41) TACR1HCRTR2TAS2R14KEAP1NFE2L2
SCHEMBL1038614 0.74 HCRTR2 (0.43) TACR1HCRTR2TAS2R14TRPM8KEAP1
SCHEMBL1040843 0.72 HCRTR2 (0.53) HCRTR2TAS2R14KEAP1NFE2L2LMNA
SCHEMBL1040093 0.69 HCRTR2 (0.54) HCRTR2MAPTALDH1A1
SCHEMBL1038697 0.68 HCRTR2 (0.56) HCRTR2KEAP1NFE2L2LMNAMAPT
SCHEMBL1041009 0.68 HCRTR2 (0.56) HCRTR2KEAP1NFE2L2LMNAMAPT
SCHEMBL1035896 0.67 KEAP1 (0.44) HCRTR2TAS2R14KEAP1NFE2L2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554239-B1 SULFONYLAMINO-ACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2011-01-26 EP disclosed
WO-2004033418-A2 SULFONYLAMINO-ACETIC DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2004-04-22 WO disclosed